World Journal of Gastrointestinal Pharmacology and Therapeutics
Overview
World Journal of Gastrointestinal Pharmacology and Therapeutics is a scientific journal, published by Baishideng Publishing Group since 2010 in English. The journal's country of origin is United States.
Details
Details
Abbr.
World J Gastrointest Pharmacol Ther
Publisher
Baishideng Publishing Group
Start
2010
End
Continuing
Frequency
Bimonthly
e-ISSN
2150-5349
Country
United States
Language
English
Recent Articles
1.
Abdel-Samiee M, Ibrahim E, Kohla M, Abdelsameea E, Salama M
World J Gastrointest Pharmacol Ther
. 2024 Nov;
15(6):97381.
PMID: 39534523
The global incidence of nonalcoholic fatty liver disease (NAFLD) is escalating considerably. NAFLD covers a range of liver conditions from simple steatosis to the more severe form known as nonalcoholic...
2.
Zaman Z, Majid Z
World J Gastrointest Pharmacol Ther
. 2024 Nov;
15(6):99226.
PMID: 39534522
Inflammatory bowel disease (IBD) has a low prevalence in the Global South, including Pakistan. While genetics and gut flora, influenced by diet and the environment, can contribute to this, we...
3.
Changela M, Pandey S, Bahirwani J, Patel N, Kaneriya M, Basida S, et al.
World J Gastrointest Pharmacol Ther
. 2024 Nov;
15(6):95532.
PMID: 39534521
Background: Inflammatory bowel disease (IBD), with its rising prevalence rates is associated with an increased risk of cardiovascular and thromboembolic events. Antiplatelets and/or anticoagulants agents are often prescribed but the...
4.
Scriba M, Jonas E, Chinnery G
World J Gastrointest Pharmacol Ther
. 2024 Nov;
15(6):99097.
PMID: 39534520
Background: Corrosive ingestion remains an important global pathology with high morbidity and mortality. Data on the acute management of adult corrosive injuries from sub-Saharan Africa is scarce, with international investigative...
5.
Jeyaraman N, Jeyaraman M, Mariappan T, Muthu S, Ramasubramanian S, Sharma S, et al.
World J Gastrointest Pharmacol Ther
. 2024 Nov;
15(6):98146.
PMID: 39534519
With the rising prevalence of chronic liver diseases worldwide, there exists a need to diversify our artillery to incorporate a plethora of diagnostic and therapeutic methods to combat this disease....
6.
Shukla A, Chaudhary R, Nayyar N, Gupta B
World J Gastrointest Pharmacol Ther
. 2024 Sep;
15(5):97350.
PMID: 39281265
Pain is the predominant symptom troubling patients. Pain management is one of the most important aspects in the management of surgical patients leading to early recovery from surgical procedures or...
7.
Pahari H, Peer J, Tripathi S, Singhvi S, Dhir U
World J Gastrointest Pharmacol Ther
. 2024 Sep;
15(5):97570.
PMID: 39281264
Liver transplantation (LT) in patients with hepatocellular carcinoma (HCC) and chronic liver disease (CLD) is limited by factors such as tumor size, number, portal venous or hepatic venous invasion and...
8.
Porwal A, Gandhi P, Kulkarni D, Bhagwat G, Kamble P
World J Gastrointest Pharmacol Ther
. 2024 Sep;
15(5):97330.
PMID: 39281263
Background: Functional constipation (FC) is a common gastrointestinal disorder characterized by abdominal pain and bloating, which can greatly affect the quality of life of patients. Conventional treatments often yield suboptimal...
9.
Nagesh V, Tran H, Elias D, Kianifar Aguilar I, Sethi T, Menon A, et al.
World J Gastrointest Pharmacol Ther
. 2024 Sep;
15(5):95467.
PMID: 39281262
infection (CDI) has been increasing due to the effect of recurrent hospitalizations. The use of antibiotics has been shown to alter the gut microbiome and lead to CDIs. The treatment...
10.
Jindal N, Jena A, Kumar K, Padhi B, Sharma R, Jearth V, et al.
World J Gastrointest Pharmacol Ther
. 2024 Sep;
15(5):97261.
PMID: 39281261
Background: The gastrointestinal symptom rating scale (GSRS) is a questionnaire in English language which is designed to assess the clinical symptoms in patients with irritable bowel syndrome (IBS) and peptic...